Stock listing
Scopus Biopharma, Inc.
Selected listing: SCPS · OTC · USD · US
Scopus Biopharma, Inc. (OTC:SCPS), Health Technology. Latest release Nov 7, 2023: Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Presents Compelling…
- Ticker
- OTC:SCPS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
About Scopus Biopharma, Inc.
The company focuses on developing innovative biopharmaceutical solutions. Investors can find detailed information about its operations and performance on the 6ix platform.
Latest news from Scopus Biopharma, Inc.
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of Cancer
November 6, 2023
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of Cancer
November 1, 2023
OTC Markets Group Welcomes New OTCQB Companies – December 27
December 27, 2022
Research Scopus Biopharma, Inc.
Scopus Biopharma, Inc. company profile
View the public company page for Scopus Biopharma, Inc. on 6ix.
Scopus Biopharma, Inc. news
Read company news and market updates connected to Scopus Biopharma, Inc..
Scopus Biopharma, Inc. investor events
Find investor webinars, events, and replay context for Scopus Biopharma, Inc..